Amgen Inc.
Brak transakcji
Korporacyjne papiery dłużne
Poniżej znajduje się lista obligacji Amgen Inc., posortowana według wskaźnika yield to worst. Inwestorzy często wybierają obligacje spółek ze względu na ich większą stabilność w okresach zmienności rynkowej. Analizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol | Rentowność % | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Rating S&P | Ocena kredytowa Fitch | Emitent |
|---|---|---|---|---|---|---|---|---|---|
| 6,22% | 91,18% | 5,375% | 2043-05-15 | 184,88 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 6,06% | 133,47% | 8,125% | 2097-04-01 | 100 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 6,02% | 96,01% | 5,750% | 2063-03-02 | 2,75 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,94% | 77,26% | 4,400% | 2062-02-22 | 1,13 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,93% | 96,22% | 5,650% | 2053-03-02 | 4,25 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,91% | 86,07% | 4,875% | 2053-03-01 | 1 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,91% | 96,33% | 5,650% | 2056-02-19 | 750 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,89% | 83,96% | 4,663% | 2051-06-15 | 3,54 B USD | 1 000,00 USD | BBB+ | — | Amgen, Inc. | |
| 5,89% | 83,69% | 4,563% | 2048-06-15 | 1,42 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,87% | 77,83% | 4,200% | 2052-02-22 | 881,72 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,82% | 95,89% | 5,500% | 2046-02-19 | 500 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,81% | 83,91% | 4,400% | 2045-05-01 | 2,25 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,77% | 58,97% | 2,770% | 2053-09-01 | 939,92 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,76% | 98,85% | 5,650% | 2042-06-15 | 415,42 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,75% | 98,31% | 5,600% | 2043-03-02 | 2,75 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,71% | 69,82% | 3,375% | 2050-02-21 | 1,27 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,70% | 94,35% | 5,150% | 2041-11-15 | 728,89 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,69% | 92,41% | 4,950% | 2041-10-01 | 600 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,59% | 107,22% | 6,400% | 2039-02-01 | 333,01 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,58% | 76,92% | 3,150% | 2040-02-21 | 1,48 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,58% | 71,63% | 2,800% | 2041-08-15 | 543,17 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,58% | 64,29% | 3,000% | 2052-01-15 | 598,26 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,55% | 101,82% | 5,750% | 2040-03-15 | 373,1 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,50% | 112,16% | 6,900% | 2038-06-01 | 253,28 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,32% | 108,66% | 6,375% | 2037-06-01 | 478,88 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,22% | 97,17% | 4,850% | 2036-02-19 | 1,75 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 5,00% | 94,74% | 4,663% | 2051-06-15 | 57 K USD | 1 000,00 USD | BBB+ | — | Amgen, Inc. | |
| 5,00% | 101,35% | 5,250% | 2033-03-02 | 4,25 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 4,97% | 95,63% | 4,200% | 2033-03-01 | 750 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 4,93% | 92,23% | 3,350% | 2032-02-22 | 1 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 4,89% | 85,98% | 2,000% | 2032-01-15 | 986,62 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 4,79% | 97,65% | 4,000% | 2029-09-13 | 700 M GBP | 1 000,00 GBP | BBB+ | BBB+ | Amgen, Inc. | |
| 4,76% | 89,70% | 2,300% | 2031-02-25 | 1,25 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 4,73% | 99,60% | 2,600% | 2026-08-19 | 1,25 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 4,72% | 97,82% | 4,200% | 2031-02-19 | 1 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 4,72% | 92,37% | 2,450% | 2030-02-21 | 1,25 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 4,71% | 101,71% | 5,250% | 2030-03-02 | 2,75 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 4,63% | 98,29% | 4,050% | 2029-08-18 | 1,25 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 4,56% | 96,07% | 3,000% | 2029-02-22 | 750 M USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 4,55% | 100,93% | 5,150% | 2028-03-02 | 3,75 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 4,53% | 98,41% | 2,200% | 2027-02-21 | 1,72 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 4,50% | 94,13% | 1,650% | 2028-08-15 | 1,23 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 4,48% | 98,29% | 3,200% | 2027-11-02 | 1 B USD | 1 000,00 USD | BBB+ | BBB+ | Amgen, Inc. | |
| 4,30% | 100,55% | 5,500% | 2026-12-07 | 475 M GBP | 1 000,00 GBP | BBB+ | BBB+ | Amgen, Inc. | |
| 3,23% | 90,90% | 2,770% | 2053-09-01 | 81 K USD | 1 000,00 USD | BBB+ | — | Amgen, Inc. | |
| — | — | 4,563% | 2048-06-15 | 250 K USD | 1 000,00 USD | BBB+ | — | Amgen, Inc. |